Convey Health Solutions Holdings, Inc. (CNVY) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
100 SE 3RD AVENUE FT. LAUDERDALE, FL 33394 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 809 - Miscellaneous Health And Allied Services, Not (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 6/30/2022 MRQ | 12/31/2021 | |||
|---|---|---|---|---|
| ASSETS | ||||
| Current Assets | ||||
| Cash, cash equivalents, and short-term investments | 38,811 | |||
| Cash and cash equivalents | 38,811 | |||
| Receivables | 69,813 | |||
| Inventory, net of allowances, customer advances and progress billings | 14,060 | |||
| Inventory | 14,060 | |||
| Prepaid expense | 8,175 | |||
| Advances on inventory purchases | 23 | |||
| Other current assets | 983 | |||
| Other undisclosed current assets | 388 | |||
| Total current assets: | 132,253 | |||
| Noncurrent Assets | ||||
| Property, plant and equipment | 20,400 | |||
| Intangible assets, net (including goodwill) | 675,220 | |||
| Goodwill | 455,206 | |||
| Intangible assets, net (excluding goodwill) | 220,014 | |||
| Other noncurrent assets | 2,030 | |||
| Total noncurrent assets: | 697,650 | |||
| TOTAL ASSETS: | 829,903 | |||
| LIABILITIES AND EQUITY | ||||
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 62,426 | |||
| Accounts payable | 13,868 | |||
| Accrued liabilities | 48,558 | |||
| Deferred revenue | 7,472 | |||
| Other undisclosed current liabilities | 498 | |||
| Total current liabilities: | 70,396 | |||
| Noncurrent Liabilities | ||||
| Long-term debt and lease obligation | 189,643 | |||
| Long-term debt, excluding current maturities | 189,643 | |||
| Liabilities, other than long-term debt | 31,587 | |||
| Deferred income tax liabilities | 25,992 | |||
| Other liabilities | 5,595 | |||
| Other undisclosed noncurrent liabilities | 528 | |||
| Total noncurrent liabilities: | 221,758 | |||
| Total liabilities: | 292,154 | |||
| Equity | ||||
| Equity, attributable to parent | 537,749 | |||
| Common stock | 732 | |||
| Additional paid in capital | 570,252 | |||
| Accumulated other comprehensive income | 31 | |||
| Accumulated deficit | (33,266) | |||
| Total equity: | 537,749 | |||
| TOTAL LIABILITIES AND EQUITY: | 829,903 | |||
Income Statement (P&L) ($ in thousands)
| 6/30/2022 TTM | 12/31/2021 | ||
|---|---|---|---|
| Revenues | 337,596 | ||
| Cost of revenue (Cost of Goods and Services Sold) | (639) | ||
| Gross profit: | 336,957 | ||
| Operating expenses | (325,884) | ||
| Other undisclosed operating income | 639 | ||
| Operating income: | 11,712 | ||
| Nonoperating expense | (22,309) | ||
| Interest and debt expense | (5,015) | ||
| Loss from continuing operations before equity method investments, income taxes: | (15,612) | ||
| Other undisclosed income from continuing operations before income taxes | 5,015 | ||
| Loss from continuing operations before income taxes: | (10,597) | ||
| Income tax benefit | 619 | ||
| Loss from continuing operations: | (9,978) | ||
| Loss before gain (loss) on sale of properties: | ✕ | (9,978) | |
| Net loss available to common stockholders, diluted: | (9,978) | ||
Comprehensive Income ($ in thousands)
| 6/30/2022 TTM | 12/31/2021 | ||
|---|---|---|---|
| Net loss: | (9,978) | ||
| Comprehensive loss: | (9,978) | ||
| Other undisclosed comprehensive loss, net of tax, attributable to parent | (47) | ||
| Comprehensive loss, net of tax, attributable to parent: | (10,025) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.